The effects of ER morphology on synaptic structure and function in Drosophila melanogaster
JB Summerville, JF Faust, E Fan… - Journal of cell …, 2016 - journals.biologists.com
Hereditary spastic paraplegia (HSP) is a set of genetic diseases caused by mutations in one
of 72 genes that results in age-dependent corticospinal axon degeneration accompanied by …
of 72 genes that results in age-dependent corticospinal axon degeneration accompanied by …
Immune-related adverse events are associated with improved outcomes in ICI-treated renal cell carcinoma patients.
645 Background: With the approval of immune-checkpoint inhibitors (ICI) as first and second
line agents for treating metastatic renal cell carcinoma (RCC), immune-related adverse …
line agents for treating metastatic renal cell carcinoma (RCC), immune-related adverse …
[HTML][HTML] Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinoma
V Patel, R Elias, J Formella… - … for Immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Immune checkpoint inhibitors (ICIs) such as nivolumab and ipilimumab have improved
outcomes in metastatic renal cell carcinoma (mRCC) patients, but they are also associated …
outcomes in metastatic renal cell carcinoma (mRCC) patients, but they are also associated …
[PDF][PDF] High annualized bleeding rates in pediatric patients with inherited platelet function disorders
Contributions: S. Saini and A. Zia conceptualized, designed, and performed research. S.
Saini, S. Zhang, and A. Zia analyzed the data. S. Yates and R. Sarode blindly and …
Saini, S. Zhang, and A. Zia analyzed the data. S. Yates and R. Sarode blindly and …
Acute interstitial nephritis (AIN) following immune checkpoint inhibitor (ICI) therapy in metastatic RCC (mRCC) as a potential predictor of response.
VM Patel, R Elias, J Formella, W Schwartzman… - 2020 - ascopubs.org
674 Background: ICIs such as nivolumab (N) have improved outcomes in mRCC patients
(pts), but are also associated with immune-related adverse events. As has been shown in …
(pts), but are also associated with immune-related adverse events. As has been shown in …
IMMU-10. ENGINEERED PD-L1 RECEPTORS AUGMENT ANTI-TUMOR ACTIVITY OF HER2 CAR T CELLS IN HIGH GRADE GLIOMA
D Landi, K Fousek, M Mukherjee, A Shree… - Neuro …, 2017 - ncbi.nlm.nih.gov
IMMU-10. ENGINEERED PD-L1 RECEPTORS AUGMENT ANTI-TUMOR ACTIVITY OF HER2
CAR T CELLS IN HIGH GRADE GLIOMA - PMC Back to Top Skip to main content NIH NLM …
CAR T CELLS IN HIGH GRADE GLIOMA - PMC Back to Top Skip to main content NIH NLM …
[CITATION][C] Election of Officers
JL Erwin, CRB Whitehead, JM Faarup, R Mapes… - 1997